• Contact/
  • Home/

  • About
  • Team
  • Portfolio
  • Exit History
  • News

  • About
  • Team
  • Portfolio
  • Exit History
  • News

  • Advent Life Sciences
  • Advent Life Sciences

Page 5 of 25

 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10Next >End >>
28.06.2021Amphista Therapeutics Expands Research Team by Appointing Martin O’Rourke as Head of Drug Discovery and James Osborne as Director of Chemistry

Press Release

23.06.2021Aleta Biotherapeutics and Cancer Research UK collaborate to advance blood cancer therapy into the clinic

Press Release

17.06.2021Aura Biosciences Assembles New Bladder Cancer Focused Scientific Advisory Board

Press Release

08.06.2021Aura Biosciences Appoints Sapna Srivastava, Ph.D., to its Board of Directors

In The News

14.04.2021Highlight Therapeutics to present data from Phase 2 immunotherapy studies of liver metastases and melanoma data at AACR Virtual Annual Meeting 202

Press Release

14.04.2021Aura Biosciences Announces Publication of Data in Cancer Immunology Research Supporting the Immune Mediated Mechanism of Action of the Virus-Like Drug Conjugate (VDC) Technology Platform with Broad Application in Cancer Treatment

Press Release

12.04.2021Francesco Maria Lavino appointed Chief Executive Officer of F2G Ltd

Press Release

01.04.2021 Eloxx Pharmaceuticals Acquires Zikani Therapeutics

Press Release

24.03.2021Aura Biosciences Expands Executive Leadership Team with the Appointment of Mark De Rosch, Ph.D., as Chief Operating Officer

Press Release

22.03.2021Aura Biosciences Announces Oversubscribed $80 Million Financing

Press Release



  • Privacy Policy
  • Legal and Regulatory Matters

©2022 Advent Life Sciences